COMBINED TREATMENT WITH SUSTAINED-RELEASE THEOPHYLLINE AND BETA2-ADRENOCEPTOR-STIMULATING AGENTS IN CHRONIC CHILDHOOD ASTHMA

被引：33

|

作者：

LONNERHOLM, G ^{[1
]}

FOUCARD, T ^{[1
]}

LINDSTROM, B ^{[1
]}

机构：

[1] UNIV UPPSALA HOSP,DEPT PAEDIAT,S-75014 UPPSALA,SWEDEN

来源：

BRITISH MEDICAL JOURNAL | 1981年 / 282卷 / 6269期

关键词：

D O I：

10.1136/bmj.282.6269.1029

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1029 / 1031

页数：3

相关论文

共 34 条

[31] Chronic treatment with the Beta-2-adrenoceptor (β2AR) inverse agonists produces receptor upregulation in a murine model of asthma
Dudekula, NB
Callaerts, Z
Bond, RA
FASEB JOURNAL, 2004, 18 (04): : A234 - A235
[32] A COMPARATIVE-STUDY OF THE EFFICACY AND SIDE-EFFECTS OF A SIMPLE THEOPHYLLINE PREPARATION (EUSPIRAX) AND A SUSTAINED-RELEASE PREPARATION (EUPHYLLIN RETARD) - A CONTRIBUTION TO THE LONG-TERM TREATMENT OF BRONCHIAL-ASTHMA
EITNER, L
WETTENGEL, R
SCHNITKER, J
PRAXIS UND KLINIK DER PNEUMOLOGIE, 1983, 37 (06): : 236 - 242
[33] ENHANCED NEUROTRANSMITTER RELEASE IN THE RAT-HEART AFTER CHRONIC EPINEPHRINE TREATMENT - NO PREJUNCTIONAL BETA(2)-ADRENOCEPTOR MEDIATED FACILITATION
APPARSUNDARAM, S
EIKENBURG, DC
FASEB JOURNAL, 1994, 8 (04): : A108 - A108
[34] PHARMACOKINETICS AND PHARMACODYNAMICS OF 3 SUSTAINED-RELEASE THEOPHYLLINE PREPARATIONS (THEOGRAD, 350 MG THEOLAIR RETARD, AND 300 MG THEOLIN RETARD) IN STEADY-STATE IN 6 NORMALS AND 6 PATIENTS WITH CHRONIC ASTHMATIC BRONCHITIS .2. LUNG-FUNCTION
VANDERVET, APH
KREUKNIET, J
DROST, RH
MAES, RAA
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1985, 23 (07) : 339 - 344

← 1 2 3 4 →